glp-1 agonist therapy New Guidelines for Type 2 Diabetes in 2025 GLP-1 Personalized Treatment for Weight
Description
A molecular link between diabetes and breast cancer: therapeutic potential of repurposing incretin-based therapies for breast cancer
Activation of GLP-1R engages cAMP/PKA and PI3K/Akt pathways overlapping with insulin receptor signaling
Safety analysis showed no increased risk of infections (SGLT2i) or pancreatitis (GLP-1RAs)
Endocrinology 166 (4), bqaf028
R.BarbieriM.FavaI.DesiderioM.CoppolaC.MarfellaR.et al (2016)
Karan Chhabra, bariatric surgeon and senior study author
